美国两个大型人群宫颈筛查后的相似风险模式:对临床指南的意义
本研究比较新墨西哥HPV Pap登记库与Kaiser Permanente北加州两个大型数据集在宫颈筛查结果后组织学CIN3+的累积风险。结果显示不同筛查结果下5年CIN3+风险在两个人群间相似,支持基于风险的管理阈值。
要点
- 不同筛查结果下5年CIN3+风险在两数据集间相似。
- 细胞学阴性5年CIN3+风险分别为0.52%和0.30%,差异有统计学意义(P<.001)。
- 年龄分层分析变异性较大,尤其是30岁以下女性,但风险分层模式可比。
核心结论
- 两个来自不同真实临床实践设置的大型队列结果相似,支持基于风险的管理阈值适用于美国临床人群和实践设置。
研究设计与样本
- 回顾性队列研究,使用logistic-Weibull生存模型估计并比较组织学CIN3+的累积3年和5年风险。
- 新墨西哥HPV Pap登记库纳入2007-2011年筛查的21-64岁女性453,618例。
- Kaiser Permanente北加州纳入2003-2013年筛查的21-64岁女性1,307,528例。
- 结果按年龄和基线筛查结果分层:细胞学阴性、ASC-US(伴或不伴HPV分流)、低级别鳞状上皮内病变、高级别鳞状上皮内病变。
主要发现
- 5年CIN3+风险:细胞学阴性新墨西哥0.52% vs Kaiser 0.30%(P<.001)。
- 5年CIN3+风险:HPV阴性且ASC-US新墨西哥0.72% vs Kaiser 0.49%(P=.5)。
- 5年CIN3+风险:ASC-US新墨西哥3.4% vs Kaiser 3.4%(P=.8)。
- 5年CIN3+风险:HPV阳性且ASC-US新墨西哥7.7% vs Kaiser 7.1%(P=.3)。
- 5年CIN3+风险:低级别鳞状上皮内病变新墨西哥6.5% vs Kaiser 5.4%(P=.009);高级别鳞状上皮内病变新墨西哥53.1% vs Kaiser 50.4%(P=.2)。
关键数值与推荐
- CIN2+风险和3年风险在两个人群间趋势相似。
- 年龄分层分析显示更多变异性,尤其是30岁以下女性,但风险分层模式可比。
临床怎么用
- 当前美国宫颈筛查和管理建议基于筛查结果后组织学高级别CIN的比较风险。
局限性
- 年龄分层分析显示更多变异性,尤其是30岁以下女性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare the risks of histologic high-grade cervical intraepithelial neoplasia (CIN) or worse after different cervical cancer screening test results between two of the largest U.S. clinical practice research data sets. METHODS: The New Mexico Human Papillomavirus (HPV) Pap Registry is a statewide registry representing a diverse population experiencing varied clinical practice delivery. Kaiser Permanente Northern California is a large integrated health care delivery system practicing routine HPV cotesting since 2003. In this retrospective cohort study, a logistic-Weibull survival model was used to estimate and compare the cumulative 3- and 5-year risks of histologic CIN 3 or worse among women aged 21-64 years screened in 2007-2011 in the New Mexico HPV Pap Registry and 2003-2013 in Kaiser Permanente Northern California. Results were stratified by age and baseline screening result: negative cytology, atypical squamous cells of undetermined significance (ASC-US) (with or without HPV triage), low-grade squamous intraepithelial lesion, and high-grade squamous intraepithelial lesion. RESULTS: There were 453,618 women in the New Mexico HPV Pap Registry and 1,307,528 women at Kaiser Permanente Northern California. The 5-year CIN 3 or worse risks were similar within screening results across populations: cytology negative (0.52% and 0.30%, respectively, P<.001), HPV-negative and ASC-US (0.72% and 0.49%, respectively, P=.5), ASC-US (3.4% and 3.4%, respectively, P=.8), HPV-positive and ASC-US (7.7% and 7.1%, respectively, P=.3), low-grade squamous intraepithelial lesion (6.5% and 5.4%, respectively, P=.009), and high-grade squamous intraepithelial lesion (53.1% and 50.4%, respectively, P=.2). Cervical intraepithelial neoplasia grade 2 or worse risks and 3-year risks had similar trends across populations. Age-stratified analyses showed more variability, especially among women aged younger than 30 years, but patterns of risk stratification were comparable. CONCLUSION: Current U.S. cervical screening and management recommendations are based on comparative risks of histologic high-grade CIN after screening test results. The similar results from these two large cohorts from different real-life clinical practice settings support risk-based management thresholds across U.S. clinical populations and practice settings.
引用
- Gage JC, Hunt WC, Schiffman M, et al. Similar Risk Patterns After Cervical Screening in Two Large U.S. Populations: Implications for Clinical Guidelines. Obstet Gynecol. 2016. PMID: 27824767. doi:10.1097/AOG.0000000000001721
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。